Search clinical trials for: ASP1941
Total 50 results
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP1941United States
-
Astellas Pharma IncCompletedA Study to Investigate the Effect of Food on the Absorption, Distribution and Elimination of ASP1941Healthy | Pharmacokinetics of ASP1941Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP1941United States
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of ASP1941Japan
-
Astellas Pharma IncAstellas Pharma Taiwan, Inc.CompletedHealthy | Pharmacokinetics of ASP1941Taiwan
-
Astellas Pharma Global Development, Inc.CompletedHealthy Volunteers | Pharmacokinetics of ASP1941United States
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of ASP1941Japan
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of ASP1941Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP1941 | Pharmacokinetics of MitiglinideJapan
-
Ohio State UniversityNational Institute on Aging (NIA)RecruitingChronic Venous Leg UlcersUnited States
-
TheracosCompletedStudy to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy SubjectsType 2 Diabetes MellitusUnited States
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusUnited States, Hungary, Poland, Romania, Italy, United Kingdom
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusHungary, Poland, Slovakia, Netherlands
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics of IpragliflozinUnited Kingdom
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedDiabetes Mellitus, Type 2United States, India, Philippines, Colombia, Mexico
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma Korea, Inc.CompletedType 2 Diabetes MellitusKorea, Republic of
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma Europe B.V.CompletedType 2 Diabetes MellitusGermany
-
Astellas Pharma IncCompletedHealthy Subjects | Cardiac RepolarizationUnited States
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedLiver DiseaseUnited States
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma Korea, Inc.Terminated
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedType 1 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedType 1 Diabetes MellitusJapan
-
Astellas Pharma IncTerminatedA Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes MellitusType II Diabetes MellitusTaiwan, Korea, Republic of
-
Astellas Pharma Europe B.V.CompletedType 2 Diabetes MellitusRussian Federation
-
Astellas Pharma IncCompletedType II Diabetes MellitusTaiwan, Korea, Republic of
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Astellas Pharma IncCompletedDiabetes Mellitus, Type 2United States
-
Astellas Pharma IncCompleted
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Bioavailability of IpragliflozinUnited Kingdom
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedType 2 DiabetesJapan